Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement.
Journal: The lancet. Diabetes & endocrinology
Published: November 24, 2024
Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by Different Methodologies: IMA, LC-MS/MS, and RIA.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 02, 2024
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 04, 2023
Thyroglobulin Cutoff Values for Detecting Excellent Response to Therapy in Patients With Differentiated Thyroid Cancer.
Journal: Journal of the Endocrine Society
Published: March 01, 2023
Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.
Journal: European thyroid journal
Published: February 21, 2023
An Assessment of Diversity, Inclusion, and Health Equity Training in Endocrinology Fellowship Programs in the United States.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: June 08, 2022
Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day.
Journal: Cancer medicine
Published: May 24, 2022
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 22, 2022
A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 09, 2021
Graves' disease patients with iron deficiency anemia: serologic evidence of co-existent autoimmune gastritis.
Journal: American journal of blood research
Published: March 02, 2021
Response to Rosário and Souza Côrtes re: "The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence".
Journal: Thyroid : official journal of the American Thyroid Association
Published: June 03, 2020
Last Updated: 09/26/2026